News About: Pharm. Industry
GSK to restart marketing of Duac gel
GlaxoSmithKline Korea said Monday its dermatology business division will re-release Duac gel used to treat acne, particularly cystic acne at the end of this month.
The active ingredients in Duac gel are clindamycin...
Yuyu to release dietary supplement in 2013
Yuyu Pharmaceutical Co. said Monday it has entered into a marketing and supply agreement with Germany based Certmedica International to market Formoline L112 (polyglycosamine L112), a dietary supplement, in Korea from...
TNT Korea teams up with Mertz Korea through partnership
TNT Korea said Monday it has signed a partnership agreement with Merz Korea to launch its delivery service for Merz’s seven medical esthetic products, including Xeomin (incobotulinumtoxin A) and Radiesse (volumizing f...
Ildong founder Yoon Yong-goo receives top CEO award
The late Yoon Yong-goo, founder of Ildong Pharmaceutical Co. was awarded the top prize in the Korean Chief Executive Officers’ 2012 CEO awards, the company said last Friday.
The award is sponsored by the Korean CEO...
Drug makers scramble to boost sales
Local drug manufacturers are seeking ways to meet their annual sales target as their revenues continue to fall in the domestic market after comprehensive price cuts of drugs by the government in April.
According t...
Sales of Viagra tumble due to generic drugs
Sales of the erectile dysfunction drug Viagra here have nearly halved in five months since production of a local generic drug was approved earlier this year, industry data showed Thursday.
According to the data com...
Ildong wins telmisartan patent
Ildong Pharmaceutical said Thursday that it has obtained a Korean patent to produce the intermediate of telmisartan (2-n-prophyl-4-methyl-6-(1-methylbenzimidazole-2-yl)-1H-benzimidazole) on a mass scale.
Telmisarta...
Gilead challenges Baraclude
Gilead Sciences, Inc., a developer of Viread (tenofovir disoproxil fumarate), is poised to enter the 200 billion won anti-hepatitis B drug market here, which has been dominated by BMS Korea’s Baraclude (entecavir).
...
Pharmaceutical firms pile up cash reserves
Korean drug companies piled up their cash reserves as they are trying to survive the government’s comprehensive price cuts, data showed Wednesday.
Cash and cash equivalents at 50 listed companies reached 1.2 trilli...
Seoul Pharm to supply Viagra ODF to Pfizer Korea
Seoul Pharmaceutical Co. Tuesday said in its regulatory filing that the company has signed an agreement with Pfizer Korea over Seoul’s Viagra (sildenafil citrate) oral disintegrating film (ODF).
Under the deal, Seo...
